Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study

Fig. 3

Factors associated with severe chronic obstructive pulmonary disease exacerbations in the health-screening cohort. The final multivariable model was adjusted for sex, age, health insurance type, COPD medication use (Methylxanthines, ICS, LABA & LAMA), heart failure, asthma, bronchiectasis, and lung cancer. CKD, chronic kidney disease; ICS, inhaled corticosteroid; LABA, long-acting beta-2 agonist; LAMA, long-acting muscarinic antagonist; SABA, systemic beta-agonist

Back to article page